143 related articles for article (PubMed ID: 12374230)
21. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
23. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
[TBL] [Abstract][Full Text] [Related]
24. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q.
Lamlum H; Al Tassan N; Jaeger E; Frayling I; Sieber O; Reza FB; Eckert M; Rowan A; Barclay E; Atkin W; Williams C; Gilbert J; Cheadle J; Bell J; Houlston R; Bodmer W; Sampson J; Tomlinson I
Hum Mol Genet; 2000 Sep; 9(15):2215-21. PubMed ID: 11001924
[TBL] [Abstract][Full Text] [Related]
25. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
Thirlwell C; Howarth KM; Segditsas S; Guerra G; Thomas HJ; Phillips RK; Talbot IC; Gorman M; Novelli MR; Sieber OM; Tomlinson IP
Br J Cancer; 2007 Jun; 96(11):1729-34. PubMed ID: 17505512
[TBL] [Abstract][Full Text] [Related]
26. Dietary factors and truncating APC mutations in sporadic colorectal adenomas.
Diergaarde B; Tiemersma EW; Braam H; van Muijen GN; Nagengast FM; Kok FJ; Kampman E
Int J Cancer; 2005 Jan; 113(1):126-32. PubMed ID: 15386431
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.
Miyoshi Y; Nagase H; Ando H; Horii A; Ichii S; Nakatsuru S; Aoki T; Miki Y; Mori T; Nakamura Y
Hum Mol Genet; 1992 Jul; 1(4):229-33. PubMed ID: 1338904
[TBL] [Abstract][Full Text] [Related]
28. APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study.
Lüchtenborg M; Weijenberg MP; Roemen GM; de Bruïne AP; van den Brandt PA; Lentjes MH; Brink M; van Engeland M; Goldbohm RA; de Goeij AF
Carcinogenesis; 2004 Jul; 25(7):1219-26. PubMed ID: 14976131
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer].
Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
Orv Hetil; 1999 Jul; 140(30):1673-9. PubMed ID: 10461447
[TBL] [Abstract][Full Text] [Related]
30. Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer.
Bisgaard ML; Jäger AC; Dalgaard P; Søndergaard JO; Rehfeld JF; Nielsen FC
Scand J Gastroenterol; 2001 Apr; 36(4):405-9. PubMed ID: 11336166
[TBL] [Abstract][Full Text] [Related]
31. APC mutations occur early during colorectal tumorigenesis.
Powell SM; Zilz N; Beazer-Barclay Y; Bryan TM; Hamilton SR; Thibodeau SN; Vogelstein B; Kinzler KW
Nature; 1992 Sep; 359(6392):235-7. PubMed ID: 1528264
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
[TBL] [Abstract][Full Text] [Related]
34. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide synthase 2 mRNA expression in relation to p53 and adenomatous polyposis coli mutations in primary colorectal adenocarcinomas.
Fransén K; Dimberg J; Osterström A; Olsson A; Söderkvist P; Sirsjö A
Surgery; 2002 Apr; 131(4):384-92. PubMed ID: 11935128
[TBL] [Abstract][Full Text] [Related]
36. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
Rowan AJ; Lamlum H; Ilyas M; Wheeler J; Straub J; Papadopoulou A; Bicknell D; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3352-7. PubMed ID: 10737795
[TBL] [Abstract][Full Text] [Related]
37. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
38. [Mutations of APC gene MCR region in sporadic colorectal adenomas and carcinomas].
Wang Y; Liu S; Hao D
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):284-6. PubMed ID: 10920985
[TBL] [Abstract][Full Text] [Related]
39. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
40. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
